Earnings Per Common Share Attributable to Pfizer Inc. Common Shareholders (Tables)

6 Months Ended

Jun. 30, 2024

Earnings Per Share [Abstract]

Schedule of Basic and Diluted Earnings Per Share

The following presents the detailed calculation of EPS:
	Three Months Ended				Six Months Ended
(MILLIONS)	June 30, 2024		July 2, 2023		June 30, 2024		July 2, 2023
EPS Numerator
Income from continuing operations attributable to Pfizer Inc. common shareholders	$	24	$	2,329	$	3,144	$	7,871
Discontinued operations––net of tax	17		(2)		12		(1)
Net income attributable to Pfizer Inc. common shareholders	$	41	$	2,327	$	3,156	$	7,870
EPS Denominator
Weighted-average number of common shares outstanding––Basic	5,666		5,646		5,662		5,640
Common-share equivalents	29		67		35		80
Weighted-average number of common shares outstanding––Diluted	5,696		5,713		5,696		5,720
Anti-dilutive common stock equivalents(a)	23		3		24		2

(a)These common stock equivalents were outstanding for the periods presented, but were not included in the computation of diluted EPS for those periods because their inclusion would have had an anti-dilutive effect.